Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Short-Term Debt

$951.00K

Quarterly · Period ending: · USD

LCTX logo

LCTX Short-Term Debt

Latest reported$951.00K
LCTX Quarterly Short-Term Debt ($0.00 → $951.00K)
High-resolution chart · PNG

LCTX short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
951,000
865,000
853,000
1,066,000
1,048,000
1,180,000
1,152,000
1,137,000
1,115,000
1,101,000
882,000
936,000
987,000
963,000
952,000
568,000
622,000
750,000
831,000
818,000
807,000
1,309,000
1,285,000
1,011,000
1,241,000
1,240,000
1,223,000
1,138,000
956,000
972,000
307,000
301,000
345,000
342,000
364,000
139,000
2,679,000
1,194,000
1,134,000
625,000
268,000
117,000
133,000
396,000
296,000
227,408
58,000
60,588
57,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135,455
3,314,033
0
0
2,690,698
1,924,156
1,307,328
716,537
353,931
306,370
100,000
0
0
0
0
0
0
0
0
0
0
0
0
2,685,392
2,454,154
0
0
0
0
0
0
0
3,350,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.